Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes
Deborah J. Wexler(Harvard University), Gabriela Montes(Group for the Analysis of Development), Louise Savoye, Janet Brown-Friday(Albert Einstein College of Medicine), Maxine Maher-Albertelli, Julizza Jimenez, Jill P. Crandall(Albert Einstein College of Medicine), Leah Holloway, Entila Xhori, Keisha Ballentine-Cargill, Julie Costello, Ashok Balasubramanyam, Sally Duran, Mabil Sibymon, Ruchi Gaba, A. Ideozu, Ian H. de Boer(The Ohio State University), M. Diane McKee(Albert Einstein College of Medicine), Chona Gullett, Saranjit Person, Tasha Stephanie Raines, Elizabeth Burgess, Cynthia Adams, Sridhar Tanukonda, Lawrence S. Phillips(Emory University), Mary K. Rhee(Atlanta VA Health Care System), Susana Gonzalez de la torre, Jennifer Lukin, H. Estrella, Folayan Morehead, Radhika Mungara, Stephanie Beringher-Massera(Group for the Analysis of Development), Erica Gonzalez, Johanna Boers(Group for the Analysis of Development), Darin E. Olson(Emory University), Peter W.F. Wilson(VA Tennessee Valley Healthcare System), CarolAnn White(Group for the Analysis of Development), April Ross
Cited by 38
Related Papers
Prediction of Coronary Heart Disease Using Risk Factor Categories
|Circulation|1998|9.6k
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
|Circulation|2003|3.8k
Obesity and the Risk of Heart Failure
|New England Journal of Medicine|2002|3k
Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.
|PubMed|1986|2.3k
Cardiovascular disease risk profiles
|American Heart Journal|1991|2.2k